APM

Aptorum Group Limited

This asset is no longer available for investment.

View all assets

Price

return (12m)

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

APM price

Aptorum Group

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment APM

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals APM

Valuation

P/E

0.00

Sector -3.34

Industry -3.34

P/BV

0.00

Sector 1.89

Industry 1.89

P/Revenue (PSR)

Sector 2.04

Industry 2.04

EV/EBITDA

Sector -219.22

Industry -219.22

EV/EBIT

Sector -47.87

Industry -47.87

P/EBITDA

Sector -22.33

Industry -22.33

P/EBIT

Sector -28.88

Industry -28.88

P/Total Assets

Sector 1.11

Industry 1.11

P/Net Current Assets

0.00

Sector -9.46

Industry -9.46

P/Working Capital

0.00

Sector -148.60

Industry -148.60

EPS

-1.13

Sector -1.78

Industry -1.78

BVPS

0.06

Sector 1.98

Industry 1.98

Efficiency

Gross Margin

100.00%

Sector 41.35%

Industry 41.35%

EBITDA Margin

Sector -17,192.92%

Industry -17,192.92%

EBIT Margin

-100.00%

Sector -35.47%

Industry -35.47%

Net Profit Margins

-95.91%

Sector -35.90%

Industry -35.90%

Asset Turnover

Sector 0.03

Industry 0.03

Profitability

ROE

-1,960.62%

Sector -57.36%

Industry -57.36%

ROA

-5.38%

Sector -59.44%

Industry -59.44%

ROIC

Sector -2,371.18%

Industry -2,371.18%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

0.45

Sector 2.91

Industry 2.91

Net Debt / EBITDA

Sector -21.45

Industry -21.45

Net Debt / EBIT

Sector -8.32

Industry -8.32

Net Debt / Equity

Sector -33,201.77

Industry -33,201.77

Gross Debt / Equity

Sector -0.85

Industry -0.85

Equity/Assets

0.00

Sector 0.46

Industry 0.46

Liabilities/Assets

0.27

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

18.56%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals APM

DRAG THE FRAME TO SEE MORE DATA

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
APM Aptorum Group Limited	$0.00	-100.00%	0.00%	0.00	0.00	-1,960.62%	-95.91%
PFE Pfizer Inc.	$28.25	23.91%	6.23%	36.34	1.84	5.07%	6.80%
ABBV AbbVie Inc.	$276.61	23.83%	2.47%	77.50	-82.49	-106.44%	9.81%
NVO Novo Nordisk A/S	$38.20	-30.25%	4.83%	9.39	4.99	53.11%	35.32%
MRK Merck & Co. Inc.	$142.71	70.83%	2.34%	113.15	8.55	7.56%	4.77%
AZN AstraZeneca PLC	$157.00	-5.51%	2.03%	19.02	4.90	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$56.36	35.67%	4.26%	12.97	5.39	41.59%	18.87%
ZTS Zoetis Inc.	$75.14	-45.73%	2.81%	11.76	9.85	83.77%	27.69%
AMGN Amgen Inc.	$414.70	46.88%	2.41%	25.51	19.08	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$750.47	35.09%	0.49%	17.80	2.43	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$109.37	70.62%	0.00%	31.72	91.40	288.13%	24.86%
MCK McKesson Corporation	$962.85	26.60%	0.36%	24.20	-28.76	-118.84%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$489.96	20.15%	0.00%	29.37	6.39	21.76%	35.00%
CAH Cardinal Health Inc.	$237.45	53.30%	0.86%	32.46	-20.43	-62.92%	0.67%
ARGX argenx SE	$803.12	0.78%	0.00%	15.66	4.13	26.35%	25.62%
HRMY Harmony Biosciences Holdings Inc.	$36.74	38.43%	0.00%	12.88	2.34	18.14%	18.88%
BIIB Biogen Inc.	$228.84	56.13%	0.00%	40.08	1.77	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

APM - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Aptorum Group

Aptorum Group Limited

Average Investor10 user rating

4.0 (2 people)

United States

16 years

Founded: 2010

2018

Time since IPO - 8 years

26

Employees

Aptorum Group Limited (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $47.00 Thousand.

The company employs approximately 26 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Aptorum Group Limited reported $960.82 Thousand in revenue, generating net income of $-921.49 Thousand.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker APM.

Market cap

Net worth

$47.00 Thousand

$47,000.00

Assets

$17.13 million

$17,133,926.00

Total Shares Outstanding

814.38 Thousand

814,000

Average Daily Trading Volume

$160.54 Thousand

$160,536.00

Sector

Health Care

Industry

Biotechnology

APM

APM revenue and profits

Financial Results APM

DRAG THE FRAME TO SEE MORE DATA

APM cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$962.85 25,62% (12M)

P/E

24.20

0.36%

ROE

-118.84%

P/BV

-28.76

CAH - Cardinal Health

$237.45 55,85% (12M)

P/E

32.46

0.86%

ROE

-62.92%

P/BV

-20.43

ABBV - AbbVie

$276.61 23,94% (12M)

P/E

77.50

2.47%

ROE

-106.44%

P/BV

-82.49

MRK - Merck & Co.

$142.71 71,41% (12M)

P/E

113.15

2.34%

ROE

7.56%

P/BV

8.55

AZN - AstraZeneca

$157.00 --6,19% (12M)

P/E

19.02

2.03%

ROE

25.77%

P/BV

4.90

PFE - Pfizer

$28.25 24,16% (12M)

P/E

36.34

6.23%

ROE

5.07%

P/BV

1.84

BMY - Bristol-Myers Squibb

$56.36 36,98% (12M)

P/E

12.97

4.26%

ROE

41.59%

P/BV

5.39

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$962.85 25,62% (12 M)

P/L

24.20

0.36%

ROE

-118.84%

P/VP

-28.76

CAH - Cardinal Health

$237.45 55,85% (12 M)

P/L

32.46

0.86%

ROE

-62.92%

P/VP

-20.43

ABBV - AbbVie

$276.61 23,94% (12 M)

P/L

77.50

2.47%

ROE

-106.44%

P/VP

-82.49

MRK - Merck & Co.

$142.71 71,41% (12 M)

P/L

113.15

2.34%

ROE

7.56%

P/VP

8.55

AZN - AstraZeneca

$157.00 --6,19% (12 M)

P/L

19.02

2.03%

ROE

25.77%

P/VP

4.90

PFE - Pfizer

$28.25 24,16% (12 M)

P/L

36.34

6.23%

ROE

5.07%

P/VP

1.84

BMY - Bristol-Myers Squibb

$56.36 36,98% (12 M)

P/L

12.97

4.26%

ROE

41.59%

P/VP

5.39

Frequently Asked Questions

What is the price of Aptorum Group (APM) today?

The current price of Aptorum Group (APM) is $0.00. The stock began the year trading around $0.000100 and is currently priced at $0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Aptorum Group (APM) pay dividends?

Aptorum Group (APM) did not pay dividends over the past year.

Is Aptorum Group (APM) a good investment?

Aptorum Group (APM) is currently trading at $0.00 with a P/E ratio of 0.00. This represents a 0% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Aptorum Group (APM) stock?

You can buy Aptorum Group (APM) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol APM and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Aptorum Group (APM) yield today?

Over the past month, Aptorum Group (APM) has returned 0.00% — 0.00% over the past year, and 0.00% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Aptorum Group (APM) today at the current price of $0.00 your total investment would be $0.00.

Based on historical performance, the investment would have grown to approximately:

$0.00 after 1 year
$0.00 after 5 years
$0.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

APM

Aptorum Group Limited

Asset unavailable for trading

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment APM

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING APM WITH OTHER STOCK

ABOUT Aptorum Group

Aptorum Group Limited

United States

16 years

2018

26

PROFIT X PRICE APM

Financial Results APM

APM cash flow

Asset, Revenue and Profit Growth - APM

APM balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

Frequently Asked Questions